Nemesis Bioscience Closes Funding Round And Begins Preclinical Programmes
8th May 2017 Nemesis Bioscience today announced the successful completion of its latest funding round,…
read moreNemesis Bioscience was founded in 2014 to address the global threat posed by increasing bacterial resistance to commonly used antibiotics.
Nemesis will commercialise inventions to make existing antibiotics effective once more by not only overcoming resistant bacterial infections but also by preventing them in susceptible patients.
Status current
Associated Fund UK Innovation & Science Seed Fund
Sector Medical / Biotechnology
Website www.nemesisbio.com/
8th May 2017 Nemesis Bioscience today announced the successful completion of its latest funding round,…
read moreNemesis Bioscience has been successful in winning a £414, 000 award granted by the...
read moreNemesis Bioscience today announced the expansion of its presence in Aberystwyth by opening a...
read moreNew Chairman Brings “Wealth of Experience” to Pioneering Biotech Firm Simon Sturge, Executive Vice President...
read moreUpdate your browser to view this website correctly.Update my browser now